CYTOSORBENTS CORPORATION Inventory, Raw Materials, Gross
CYTOSORBENTS CORPORATION (CTSO) had Inventory, Raw Materials, Gross of $658.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory › Inventory, Gross
us-gaap:InventoryRawMaterials · last filed 2026-08-06
- 2026-06-30: Inventory, Raw Materials, Gross $658.00K.
- 2026-03-31: Inventory, Raw Materials, Gross $552.00K.
- 2025-12-31: Inventory, Raw Materials, Gross $751.00K.
- 2024-09-30: Inventory, Raw Materials, Gross $768.11K.
USD
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2026-06-30 | $658.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $552.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $751.00K 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $768.11K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $808.79K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $617.72K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $685.80K 10-Q · filed 2024-11-07 | |
| 2023-09-30 | $447.21K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $518.21K 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $597.52K 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $613.35K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $647.12K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $580.74K 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $443.31K 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $358.76K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $402.13K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $352.35K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $309.73K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $287.10K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $249.37K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $255.48K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $287.10K 10-Q · filed 2021-05-04 | $219.58K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $284.52K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $262.19K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $313.89K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $258.02K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $204.03K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $228.93K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $204.65K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $131.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $115.75K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $89.57K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $61.24K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $67.52K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $58.83K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $43.69K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $53.84K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $55.19K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $50.02K 10-K · filed 2017-03-03 | |
| 2015-09-30 | $72.49K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $76.30K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $58.34K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $68.83K 10-K · filed 2016-03-09 | |
| 2014-09-30 | $36.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $18.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $30.20K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $37.98K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $26.00K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $33.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $42.86K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $48.70K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $24.43K 10-Q · filed 2012-11-21 | |
| 2012-03-31 | $48.70K 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $0.00 10-K · filed 2013-04-03 | $57.80K 10-Q · filed 2012-11-21 |
USN
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2021-12-31 | 358.76K USN 10-Q · filed 2022-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |